Over the last 20 years, information technology (IT) has become synonymous with innovation. Few fields have adopted these principles so extensively and enthusiastically as the field of synthetic biology, and the resulting innovation is remarkable for its speed to market (getting new chemicals from lab to market in 7.4 years, compared to seven year to 40 years) and breadth of products (chemicals, medicine, food and agriculture, and even reversing extinction and solving climate change). One reason is that the field has not just embraced information technology (like BioCAD and BioLIMS), it has become information technology, with new digital genetic tools like DNA Synthesis-as-a-Service, CRISPR gene editing, and automated genomic engineering and lab equipment. The data-driven revolution of information, automation, and open source apply – and open up commercial opportunities – in industries that manage complex phenomena as diverse as traffic flow in cities and oil flow in geological formations.
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)